abstract |
(57) The present invention relates to a compound of the formula I wherein R 1 , R 2 , R 3 , m and n are as defined in the specification, which are effective as modulators of chemokine receptor activity. Is present]. These compounds are in particular modulators of the chemokine receptors CCR-1, CCR-2, CCR-2A, CCR-2B, CCR-3, CCR-4, CCR-5, CXCR-3 and / or CXCR-4. Is effective as Embedded image |